Country Reports (Pharmaceutical) Industry Analysis
Research comprehensive market analysis on Country Pharmaceutical overviews in the Pharma & Healthcare industry. Reports include data on Europe, UK, USA, Asia and other global markets.
RSS
previous
| Pharmaceuticals Markets in China (AMI00611) China's demand for pharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study... | May 2013 | £1,285£2,570€1,522€3,044$2,000$4,001 |
| BioPharmaceutical Industry in China (KEL00002) An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges"BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges" provides you with a detailed... | May 2013 | £1,600€1,895$2,491 |
| South Korea Pharmaceutical Market Outlook 2013 (GBI00406) South Korea Pharmaceutical Market Outlook 2013 Summary GBI Research's new report ""South Korea Pharmaceutical Market Outlook 2013"" provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market.... | May 2013 | £2,250€2,665$3,500 |
| Pharmaceutical Market: India (KEL00003) "Pharmaceutical Market: India, A Competitive Industry Analysis" by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This... | May 2013 | £1,600€1,895$2,491 |
| Medical Publishers - Industry Report UK (PMS02695) Plimsoll Publishing's UK Medical Publishers Analysis provides a detailed overview of the UK Medical Publishers market and delivers a comprehensive individual analysis on the top 70 companies, including ELSEVIER LTD,... | May 2013 | £350€415$545 |
| Distribution on the Pharmaceutical Market in Poland (PMR00036) 2013Keep track of changes in Polish pharmaceutical distribution. Which channels will develop most by 2015? The distribution network for pharmaceutical products in Poland is made up of several main channels, including wholesale,... | May 2013 | £1,605€1,900$2,498 |
| Manufacture and wholesale of pharmaceutical (Russia) - Industry Report (PMW08551) Plimsoll's Manufacture and wholesale of pharmaceutical (Russia) - Industry Report analysis is the most definitive and accurate study of the Manufacture and wholesale of pharmaceutical (Russia) - Industry Report sector... | May 2013 | £565€669$880 |
| Kenya Pharmaceuticals and Healthcare Report (BMI05105) Q3 2013BMI View: Kenya is an attractive prospect for companies looking to set up a manufacturing base in the region. Among the East African Community (EAC), Kenya has the deepest financial... | Apr 2013 | £755€894$1,175 |
| Russia Pharmaceuticals and Healthcare Report (BMI05634) Q2 2013BMI View: Russia's pharmaceutical market continues to be one of the most attractive in the Emerging Europe region, primarily due to its sheer market size, growing economy and increasing government... | Apr 2013 | £755€894$1,175 |
| Belarus Pharmaceuticals and Healthcare Report (BMI07559) Q2 2013BMI View: We expect the volatility in the performance of the Belarusian pharmaceutical market to continue, with political tensions increasing risks to our forecasts. Although the government aims to increase... | Apr 2013 | £755€894$1,175 |
| Philippines Pharmaceuticals and Healthcare Report (BMI05862) Q2 2013BMI View: Opportunities in the Philippines pharmaceutical and healthcare markets are currently supported by a lack of governance over drug pricing, providing short-term revenue growth opportunities for pharmaceutical firms. Expansion... | Apr 2013 | £755€894$1,175 |
| Lithuania Pharmaceuticals and Healthcare Report (BMI07521) Q2 2013BMI View: We expect the Lithuanian pharmaceutical market to continue to develop steadily over the coming years, on account of demographic and epidemiological factors. However, its small population and downward... | Apr 2013 | £755€894$1,175 |
| Puerto Rico Pharmaceuticals and Healthcare Report (BMI05532) Q2 2013BMI View: The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will continue to deteriorate due to drug patent expiration, production quality issues, increasing labour... | Apr 2013 | £755€894$1,175 |
| Indonesia Pharmaceuticals and Healthcare Report (BMI03635) Q2 2013BMI View: Commercial interest in Indonesia's healthcare sector will accelerate over the course of 2014, the year that marks the introduction of universal health insurance. The programme is expected to... | Apr 2013 | £755€894$1,175 |
| Czech Republic Pharmaceuticals and Healthcare Report (BMI03497) Q2 2013BMI View: The Czech pharmaceutical market is the most developed in terms of spending and ease of operation in the Central and Eastern European region, but it continues to present... | Apr 2013 | £755€894$1,175 |
| United Kingdom Pharmaceuticals and Healthcare Report (BMI04822) Q2 2013BMI View: We are relatively optimistic about the longer-term performance of the UK's pharmaceutical market, on account of rising demand for services and treatment, stimulated by factors such as an... | Apr 2013 | £755€894$1,175 |
| Pharmaceuticals in Spain (EUR13982) ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at... | Apr 2013 | £400€474$623 |
| OTC Triptans in Sweden (EUR11874) The most likely customer of OTC triptans products in Sweden suffers from migraines but has not been diagnosed by a medical professional. The growing self-medication trend is therefore a key... | Apr 2013 | £600€711$934 |
| Zimbabwe Pharmaceuticals and Healthcare Report Q2 (BMI03684) 2013BMI View: We continue to view Zimbabwe as one of the least promising markets globally. We also note that it is a market for which accurate data is very difficult... | Apr 2013 | £755€894$1,175 |
| Spain Pharmaceuticals and Healthcare Report Q2 (BMI05618) 2013BMI View: The sharp drop in public pharmaceutical expenditure in Spain during the second half of 2012 warns of a continuing fall in spending on medicines in 2013. BMI notes... | Apr 2013 | £755€894$1,175 |
| Sri Lanka Pharmaceuticals and Healthcare Report Q2 (BMI06989) 2013BMI View: Economic growth will aid the development of Sri Lanka's pharmaceutical and healthcare sectors. We believe the affordability of, and fiscal contributions to, healthcare service provision will rise. Headline... | Apr 2013 | £755€894$1,175 |
| Moldova Pharmaceuticals and Healthcare Report Q2 (BMI05289) 2013BMI View: We continue to view Moldova as one of the least attractive emerging Europe markets for multinational companies. Per capita spending on medicines is low, on account of modest... | Apr 2013 | £755€894$1,175 |
| Turkey Pharmaceuticals and Healthcare Report Q2 (BMI05257) 2013BMI View: The Turkish pharmaceutical market contracted significantly in 2012, in line with our previous forecasts. We continue to hold a positive long-term view on the market's potential, owing to... | Apr 2013 | £755€894$1,175 |
| Iran Pharmaceuticals and Healthcare Report Q2 (BMI05214) 2013BMI View: We expect the downward trajectory of pharmaceutical exports into Iran to continue throughout 2013, although essential medicines will still reach patients due to unmet demands and loopholes in... | Apr 2013 | £755€894$1,175 |
| Morocco Pharmaceuticals and Healthcare Report Q2 (BMI05724) 2013BMI View: While Morocco's pharmaceutical market is small in absolute terms, its forward growth trajectory is encouraging. Positive drivers include population growth and changing epidemiological profile, as well as the... | Apr 2013 | £755€894$1,175 |
